Delivery Order SPE2DR25D2213-SPE2DR26F6DBX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens, valued at $1,309.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 26, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a ceiling value of $2,517.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a standard pharmaceutical procurement within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens valued at $1,278.50 on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,278.50 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 7, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with completion targeted for October 31, 2025. This is a firm fixed price, non-set-aside award supporting federal medical procurement needs. The contract was issued on October 30, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,165.10 on December 9, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract is structured as a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This award was not designated as a set-aside contract and was competitively awarded through the federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lantus SoloStar 100 Unit/ml insulin pens (3ml) with a ceiling value of $1,022.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The order is scheduled for completion by September 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,201.44 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens, valued at $2,172.29. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The order is due for completion by April 25, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.08 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL format) on August 5, 2025, with completion scheduled for August 6, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6DBXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a ceiling value of $1,336.94. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The order is set for ultimate completion on December 17, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen's contract portfolio demonstrates consistent delivery of pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/15/25 |